Who Is Going To Own “Medical Marijuana? Or: Those Who Define The Issue Win The Issue June 19, 2019 Doug Poretz Medical Marijuana, Op-Ed, Opinions 0 Comments In December 2018, Tilray (which Bloomberg described in their news coverage as a “Canadian pot firm”) announced a global partnership with a division of Swiss drug giant Novartis AG to develop and distribute its “medical marijuana” in legal jurisdictions around the world using the… Read More→